Client Result

Synthetic mRNA Production Landscape Assessment

Project Overview

A UK-based life science services provider was interested in learning more about the value and market landscape for synthetic mRNA production to inform a potential acquisition strategy

DeciBio Approach

Secondary Research

  • Aggregated secondary research of the therapeutic mRNA space and market demand for manufacturing
  • Summarized key specifications required and demand drivers for external manufacturing
  • Assessed the CMO competitive landscape

‍Primary Research

  • Conducted 12 in-depth stakeholder interviews with biopharma stakeholders with direct experience synthesizing and using mRNA for therapeutic applications
  • Interviewees included experts across public and private biopharma who utilize mRNA for a diverse range of therapeutic applications

Quantitative Analysis

  • Built a bottoms-up model estimating the demand and production level of synthetic mRNA today and in five years within biopharma by application area and phase of development

At a glance
12
Stakeholder Interviews
84
mRNA Clinical Trials Analyzed
21
Biopharma Companies Profiled
Outcomes

DeciBio shared research findings with the client, key takeaways included:

  • Estimated opportunity for external mRNA manufacturing in 2019 and 2024.
  • Outlined customer requirements and key considerations and recommendations to help inform the client’s acquisition strategy

Timeline

3 weeks

Geographic Scope

U.S., EU

Industry

Pharma & Biotech

capabilities

Voice-Of-Customer Research

Competitive Analysis

Addressable Market Sizing

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.